Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Dec 12;15(1):367.
doi: 10.1186/s13104-022-06261-3.

Impact of blood perilipin A levels on obesity and metabolic health

Emmanuel K Ofori  1 , Bright Selorm Letsu  2 , Seth K Amponsah  3 , John Ahenkorah  4 , Sandra Crabbe  5 , Genevieve Kwao-Zigah  2 , Sylvester Y Oppong  6 , Patrick Diaba-Nuhoho  7 , Seth D Amanquah  2
Affiliations
Observational Study

Impact of blood perilipin A levels on obesity and metabolic health

Emmanuel K Ofori et al. BMC Res Notes. .

Abstract

Objective: Perilipin A is a common protein that coats lipid surfaces preventing them from being exposed to oxidative damage. Researchers have found little consistency in the relationship between perilipin A levels in the blood and body fat. This study was a cross-sectional observational that looked at circulating perilipin A levels and how they relate to metabolic health.

Results: The participants in this study were 86 individuals with a mean age of 45.5 ± 1.2 years. Multiple clinical and metabolic indicators (age, weight, BMI, total body fat mass, triglyceride, and HOMA-IR) were shown to be inversely associated with perilipin A levels (rho = - 0.32, - 0.37, - 0.40, - 0.45, - 0.33 and - 0.29; p < 0.05 respectively). Obese persons were almost six times more likely than non-obese individuals to have lower perilipin A levels (odds ratio = 6.22, CI = 2.35-11.50, p < 0.001). Our findings underscore the important role of perilipin A proteins in metabolic health.

Keywords: Insulin resistance; Lipids; Obesity; Perilipin A.

PubMed Disclaimer

Conflict of interest statement

The authors disclose that they have no competing financial interests.

Figures

Fig. 1
Fig. 1
shows participant inclusion and study procedure
See this image and copyright information in PMC

References

    1. Reilly JJ, El-Hamdouchi A, Diouf A, Monyeki A, Somda SA. Determining the worldwide prevalence of obesity. The Lancet. 2018;391(10132):1773–1774. doi: 10.1016/S0140-6736(18)30794-3. - DOI - PubMed
    1. Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, Adams RJ, Aekplakorn W, Afsana K, Aguilar-Salinas CA. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million children, adolescents, and adults. The lancet. 2017;390(10113):2627–2642. doi: 10.1016/S0140-6736(17)32129-3. - DOI - PMC - PubMed
    1. Berrigan D, Troiano RP, Graubard BI. BMI and mortality: the limits of epidemiological evidence. The Lancet. 2016;388(10046):734–736. doi: 10.1016/S0140-6736(16)30949-7. - DOI - PMC - PubMed
    1. Gupta H, Garg S. Obesity and overweight—their impact on individual and corporate health. J Public Health. 2020;28(2):211–218. doi: 10.1007/s10389-019-01053-9. - DOI
    1. Lartey ST, Si L, Otahal P, de Graaff B, Boateng GO, Biritwum RB, Minicuci N, Kowal P, Magnussen CG, Palmer AJ. Annual transition probabilities of overweight and obesity in older adults: evidence from World Health Organization study on global AGEing and adult health. Soc Sci Med. 2020;247:112821. doi: 10.1016/j.socscimed.2020.112821. - DOI - PubMed

Publication types

LinkOut - more resources